Effect of atrial natriuretic peptide on ischemia-reperfusion injury in a porcine total hepatic vascular exclusion model

World Journal of Gastroenterology

Volumn 13, Issue 25, 2007, Pages 3487-3492

  Kobayashi, Katsumi ^a   Oshima, Kiyohiro ^b   Muraoka, Masato ^a   Akao, Takahiko ^a   Totsuka, Osamu ^a   Shimizu, Hisashi ^a   Sato, Hiroaki ^a   Tanaka, Kazumi ^a   Konno, Kenjiro ^c   Matsumoto, Koshi ^d   Takeyoshi, Izumi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

Atrial natriuretic peptide; Ischemia reperusion injury; p38 MAPK; Porchine liver; Total hepatic vascular exclusion

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR ALPHA; HANP; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BLOOD FLOW; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MINIPIG; NONHUMAN; PROTEIN BLOOD LEVEL; REPERFUSION INJURY;

EID: 34547406778     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i25.3487     Document Type: Article

References (43)

1. Delva E, Camus Y, Nordlinger B, Hannoun L, Parc F. Deriaz H, Lienhart A, Huguet C. Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 1989; 209: 211-218
2. Ekberg H, Tranberg KG, Andersson P, Jeppsson B, Bengmark S. Major liver resection: perioperative course and management. Surgery 1986; 100: 1-8
3. Bismuth H, Castaing D, Garden OJ. Major hepatic resection under total vascular exclusion. Ann Surg 1989; 210: 13-19
4. Delva E, Barberousse JP, Nordlinger B, Ollivier JM, Vacher B, Guilmet C, Huguet C. Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery 1984; 95: 309-318
5. Ohya T. Ohwada S, Kawashima Y. The effect of hypothermic perfusion with oxygenated perfluorochemical during in situ extended hepatectomy of canine liver. J Am Coll Sury 1996; 182:219-225
6. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94
7. Kangawa K. Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 1984; 118: 131-139
8. Currie MG, Geller DM, Cole BR, Boylan JG, YuSheng W, Holmberg SW, Needleman P. Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science 1983; 221: 71-73
9. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328
10. Carini R, De Cesaris MG, Splendore R, Domenicotti C, Nitti MP, Pronzato MA, Albano E. Mechanisms of hepatocyte protection against hypoxic injury by atrial natriuretic peptide. Hepatology 2003; 37: 277-285
11. Kulhanek-Heinze S, Gerbes AL, Gerwig T, Vollmar AM, Kiemer AK. Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischen-dc livers. J Hepatol 2004; 41: 414-420
12. Gerwig T, Meissner H, Bilzer M, Kiemer AK, Arnholdt H, Vollmar AM, Gerbes AL. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J Hepatol 2003; 39: 341-348
13. Gerbes AL, Vollmar AM, Kiemer AK, Bilzer M. The guanylate cyclase-coupled natriuretic peptide receptor: a newtarget for prevention of cold ischemia-reperfusion damage of the rat liver. Hepatology 1998; 28: 1309-1317
14. Bilzer M, Witthaut R, Paumgartrter G, Gerbes AL. Prevention of ischemia/reperfusion injury in the rat liver by atrial natriuretic peptide. Gastroenterology 1994; 106: 143-151
15. Kiemer AK, Gerbes AL, Bilzer M, Vollmar AM. The atrial natriuretic peptide and cGMP: novel activators of the heat shock response in rat livers. Hepatology2002; 35: 88-94
16. Kiemer AK, Vollmar AM, Bilzer M, Gerwig T, Gerbes AL. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J Hepatol 2000; 33: 236-246
17. Kiemer AK, Kulhanek-Heinze S, Gerwig T, Gerbes AL, Vollmar AM. Stimulation of p38 MAPK by hormonal preconditioning with atrial natriuretic peptide. World J Gastroenterol 2002; 8: 707-711
18. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y. The role of mitogen-activated protein kinases and the participation of intestinal congestion in total hepatic ischenda-reperfusion injury. Hepatogastroenterology 2006; 53: 243-248
19. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 2002; 131: 344-349
20. Koike N, Takeyoshi I, Ohki S, Tokumine M, Matsumoto K, Morishita Y. Effects of adding P38 mitogen-activated protein-kinase inhibitor to celsior solution in canine heart transplantation from non-heart-beating donors. Transplantation 2004; 77:286-292
21. Yoshinari D, Takeyoshi I, Kobayashi M, Koyama T, Iijima K, Ohwada S, Matsumoto K, Morishita Y. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to university of wisconsin solution on reperfusion injury in liver transplantation. Transplantation 2001; 72: 22-27
22. Hashimoto N, Takeyoshi I, Yoshinari D, Tsutsumi H, Tokumine M, Totsuka O, Sunose Y, 0hwada S, Matsumoto K, Morishita Y. Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to Euro-Collins solution on reperfusion injury in canine lung transplantation1. Transplantation 2002; 74:320-326
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem1976; 72: 248-254
24. Huguet C, Nordlinger B, Galopin JJ, Bloch P, Gallot D. Normothermic hepatic vascular exclusion for extensive hepatectomy. Surg Gynecol Obstet 1978; 147: 689-693
25. Sankary HN, Yin DP, Chong AS, Ma LL, Blinder L, Shen JK, Foster P, Liu LP, Li C, Williams JW. The portosystemic shunt protects liver against ischemic reperfusion injury. Transplantation 1999; 68: 958-963
26. Sunose Y, Takeyoshi I, Tsutsumi H, Kawata K, Iwazaki S, Matsumoto K, Ohwada S, Morishita Y. The effect of FR167653 in a canine total hepatic vascular exclusion model. Hepatogastroenterology 2003; 50: 161-164
27. Battersby C, Hickman R, Saunders SJ, Terblanche J. Liver function in the pig. 1. The effects of 30 minutes' normothermic ischaemia. Br J Surg 1974; 61: 27-32
28. Kanoria S, Glantzounis G, Jalan R, Davies NA, Seifalian AM, Williams R, Davidson BR. A model to study total hepatic ischemia-reperfusion injury. Transplant Proc 2004; 36: 2586-2589
29. Nordlinger B, Douvin D, Javaudin L, Bloch P, Aranda A, Boschat M, Huguet C. An experimental study of survival after two hours of normothermic hepatic ischemia. Surg Gynecol Obstet 1980; 150: 859-864
30. Kusano T, Tamai O, Miyazato H, Isa T, Muto Y, Furukawa M. Extracorporeal bypass using a centrifugal pump during resection of malignant liver tumors, Hepatogastroenterology 1999; 46: 2483-2489
31. Hiratsuka K, Kim YI, Nakashima. K, Kawano K, Yoshida T, Kitano S. Tissue oxygen pressure during prolonged ischemia of the liver. J Surg Res 2000; 92: 250-254
32. Sangawa K, Nakanishi K, Ishino K, Inoue M, Kawada M, Sano S. Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart. Ann Thorac Surg 2004; 77: 233-237
33. Tsunoo M. Phase I study of recombinant carperitide (SUN4936), The Clinical Report 1993; 27: 1549-1565, review Japanease
34. de Broin E, Urata K, Giroux L, Lepage R, Huet PM. Effect of calcium antagonists on rat liver during extended cold preservation-reperfusion. Transplantation 1997; 63: 1547-1554
35. Bilzer M, Paumgartner G, Gerbes AL. Prolonged antagonism of alpha 1-adrenergic vasoconstriction in the rat liver by atrial natriurefic peptide. Gastroenterology 1995; 108: 803-811
36. Tsukagoshi H, Shimizu Y, Kawata T, Hisada T, Shimizu Y, Iwamae S, Ishizuka T, Iizuka K, Dobashi K, Mori M. Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation. Regul Pept 2001; 99: 21-29
37. Kiemer AK, Hartung T, Vollmar AM. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J Immunol 2000; 165: 175-181
38. Schauer RJ, Gerbes AL, Vonier D, op den Winkel M, Fraunberger P, Bilzer M. Induction of cellular resistance against Kupffer cell-derived oxidant stress: a novel concept of hepatoprotection by ischemic preconditioning. Hepatology 2003; 37: 286-295
39. Teoh N, Dela Pena A, Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology 2002; 36: 94-102
40. Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Mode K, Takashima S, Asakura M, Yamada J, Fukushinia T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res 2001; 88: 175-180
41. Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res 2000; 86:144-151
42. Donnahoo KK, Shames BD, Harken AH, Meldrum DR. Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999; 162: 196-203
43. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/threonine protein kinases and apoptosis. Exp Cell Res 2000; 256: 34-41